垂体肿瘤：分子特征、诊断与治疗靶点的新见解
Pituitary Tumors: New Insights into Molecular Features, Diagnosis and Therapeutic Targeting.
作者信息
Fedele Monica
机构信息
National Research Council (CNR), Institute of Experimental Endocrinology and Oncology (IEOS), 80145 Naples, Italy.
出版信息
Cancers (Basel). 2021 Apr 3;13(7):1697. doi: 10.3390/cancers13071697.
Abstract
In this Special Issue, a series of eight original research articles and six reviews have been collected to highlight the latest knowledge into molecular features, diagnosis and therapeutic targeting of pituitary tumors, one of the most frequent intracranial tumors and neuroendocrine neoplasms [...].
摘要
在本期特刊中，收集了一系列八篇原创研究文章和六篇综述，以突出垂体肿瘤（最常见的颅内肿瘤和神经内分泌肿瘤之一）的分子特征、诊断和治疗靶点方面的最新知识[……]
相似文献
1
Pituitary Tumors: New Insights into Molecular Features, Diagnosis and Therapeutic Targeting.垂体肿瘤：分子特征、诊断与治疗靶点的新见解
Cancers (Basel). 2021 Apr 3;13(7):1697. doi: 10.3390/cancers13071697.
2
Aggressive pituitary tumors.侵袭性垂体肿瘤
Neuroendocrinology. 2015;101(2):87-104. doi: 10.1159/000371806. Epub 2015 Jan 5.
3
Synchronous Multiple Pituitary Neuroendocrine Tumors of Different Cell Lineages.同步发生的不同细胞谱系的垂体神经内分泌肿瘤。
Endocr Pathol. 2018 Dec;29(4):332-338. doi: 10.1007/s12022-018-9545-4.
4
Advancements in Applications of Surface Modified Nanomaterials for Cancer Theranostics.表面改性纳米材料在癌症诊疗中的应用进展
Curr Drug Metab. 2017;18(11):983-999. doi: 10.2174/1389200218666171002122039.
5
Liver metastases from pituitary carcinomas mimicking visceral well-differentiated neuroendocrine tumors: a series of four cases.垂体癌肝转移酷似内脏高分化神经内分泌肿瘤：4 例系列报道。
Diagn Pathol. 2020 Jul 4;15(1):81. doi: 10.1186/s13000-020-00997-x.
6
An Institutional Experience of Tumor Progression to Pituitary Carcinoma in a 15-Year Cohort of 1055 Consecutive Pituitary Neuroendocrine Tumors.1055 例连续垂体神经内分泌肿瘤 15 年队列中肿瘤进展为垂体癌的机构经验。
Endocr Pathol. 2019 Jun;30(2):118-127. doi: 10.1007/s12022-019-9568-5.
7
Neuropathological considerations of pituitary adenomas.垂体腺瘤的神经病理学考量
Front Horm Res. 2006;34:206-235. doi: 10.1159/000091582.
8
Targeting the somatostatin receptor in pituitary and neuroendocrine tumors.针对垂体和神经内分泌肿瘤中的生长抑素受体。
Expert Opin Ther Targets. 2013 Nov;17(11):1329-43. doi: 10.1517/14728222.2013.830711. Epub 2013 Aug 31.
9
Targeting N-cadherin through fibroblast growth factor receptor-4: distinct pathogenetic and therapeutic implications.通过成纤维细胞生长因子受体-4靶向N-钙黏蛋白：独特的致病和治疗意义。
Mol Endocrinol. 2006 Nov;20(11):2965-75. doi: 10.1210/me.2006-0223. Epub 2006 Jul 20.
10
Biomarkers for Liquid Biopsies of Pituitary Neuroendocrine Tumors.垂体神经内分泌肿瘤液体活检的生物标志物
Biomedicines. 2020 Jun 2;8(6):148. doi: 10.3390/biomedicines8060148.
本文引用的文献
1
Sexual Dimorphism in Cellular and Molecular Features in Human ACTH-Secreting Pituitary Adenomas.人促肾上腺皮质激素分泌性垂体腺瘤细胞及分子特征中的性别二态性
Cancers (Basel). 2020 Mar 13;12(3):669. doi: 10.3390/cancers12030669.
2
How to Classify the Pituitary Neuroendocrine Tumors (PitNET)s in 2020.2020年如何对垂体神经内分泌肿瘤（PitNET）进行分类。
Cancers (Basel). 2020 Feb 22;12(2):514. doi: 10.3390/cancers12020514.
3
Proton Magnetic Resonance Spectroscopy Characterization of Rathke's Cleft Cysts (RCCs): Relevance to the Differential Diagnosis of Pituitary Adenomas and RCCs.拉克氏囊肿（RCCs）的质子磁共振波谱特征：与垂体腺瘤和拉克氏囊肿鉴别诊断的相关性
Cancers (Basel). 2020 Feb 4;12(2):360. doi: 10.3390/cancers12020360.
4
Exploring the Role of Novel Medical Therapies for Aggressive Pituitary Tumors: A Review of the Literature-"Are We There Yet?".探索新型医学疗法在侵袭性垂体肿瘤中的作用：文献综述——“我们到那儿了吗？”
Cancers (Basel). 2020 Jan 28;12(2):308. doi: 10.3390/cancers12020308.
5
How Valuable Is the RT-qPCR of Pituitary-Specific Transcription Factors for Identifying Pituitary Neuroendocrine Tumor Subtypes According to the New WHO 2017 Criteria?根据世界卫生组织2017年新标准，垂体特异性转录因子的逆转录定量聚合酶链反应在鉴别垂体神经内分泌肿瘤亚型方面有多大价值？
Cancers (Basel). 2019 Dec 11;11(12):1990. doi: 10.3390/cancers11121990.
6
The Role of Single-Nucleotide Polymorphisms in Pituitary Adenomas Tumorigenesis.单核苷酸多态性在垂体腺瘤肿瘤发生中的作用。
Cancers (Basel). 2019 Dec 9;11(12):1977. doi: 10.3390/cancers11121977.
7
Pituitary Adenomas and Invasiveness from Anatomo-Surgical, Radiological, and Histological Perspectives: A Systematic Literature Review.从解剖手术、放射学和组织学角度看垂体腺瘤与侵袭性：一项系统文献综述
Cancers (Basel). 2019 Dec 4;11(12):1936. doi: 10.3390/cancers11121936.
8
Patient-Reported Outcome (PRO) as an Addition to Long-Term Results after High-Precision Stereotactic Radiotherapy in Patients with Secreting and Non-Secreting Pituitary Adenomas: A Retrospective Cohort Study up to 17-Years Follow-Up.患者报告结局（PRO）作为分泌性和非分泌性垂体腺瘤患者高精度立体定向放射治疗后长期结果的补充：一项长达17年随访的回顾性队列研究。
Cancers (Basel). 2019 Nov 27;11(12):1884. doi: 10.3390/cancers11121884.
9
The Role of Aberrant DNA Methylation in Misregulation of Gene Expression in Gonadotroph Nonfunctioning Pituitary Tumors.异常DNA甲基化在促性腺激素非功能性垂体瘤基因表达失调中的作用
Cancers (Basel). 2019 Oct 25;11(11):1650. doi: 10.3390/cancers11111650.
10
Toxicity Profiles of Fractionated Radiotherapy, Contemporary Stereotactic Radiosurgery, and Transsphenoidal Surgery in Nonfunctioning Pituitary Macroadenomas.非功能性垂体大腺瘤的分割放疗、现代立体定向放射外科和经蝶窦手术的毒性特征
Cancers (Basel). 2019 Oct 26;11(11):1658. doi: 10.3390/cancers11111658.
Zotero 插件